Clinical and experimental medicine

CDKN1A and cell aging are linked to immune resistance in advanced lung cancer

Updated

Abstract

High expression is associated with worse overall survival (OS) and progression-free survival (PFS) in advanced lung adenocarcinoma (LUAD) treated with (HR = 2.74, P = 0.007; HR = 1.78, P = 0.045).

  • CDKN1A expression correlates positively with an immunosuppressive tumor microenvironment characterized by extracellular matrix, cancer-associated fibroblasts, and myeloid-derived suppressor cells.
  • Single-cell RNA sequencing validated differences in the tumor microenvironment and cellular communication between tumors with high and low CDKN1A expression in advanced LUAD.
  • High CDKN1A expression is correlated with increased activity of specific signaling pathways and enhanced communication with stromal and endothelial cells.
  • In advanced LUAD, CDKN1A is associated with and may contribute to resistance to immunotherapy, suggesting a need for alternative therapeutic strategies.

Simplified

Key numbers

2.74
for associated with high expression in patients.
1.78
for associated with high expression in patients.
P < 0.05
Correlation
Statistical significance of the correlation between expression and CAF abundance.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declarations. Conflict of interest: F Duan, P Cui, Y Shi, L Zhang, X Mi, Y Xu, G Wang, and S Cai are employees of Burning Rock Biotech. The other authors declare no competing interests. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free